Xin-Sheng Lei

Title: Innovations by Inventor Xin-Sheng Lei

Introduction

Xin-Sheng Lei is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as inhibitors for metalloproteinases. His work is particularly relevant for the treatment of obstructive airway diseases.

Latest Patents

Xin-Sheng Lei holds two patents that focus on (2,5-dioxoimidazolidin-i-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors. These inventions provide compounds that are effective against metalloproteinase MMP-12, which is crucial for treating conditions such as chronic obstructive pulmonary disease (COPD). The compounds are defined by specific variables outlined in the patent specifications, showcasing their potential therapeutic applications.

Career Highlights

Xin-Sheng Lei is associated with Medivir AB, a company known for its innovative approaches in drug development. His work at Medivir has allowed him to focus on creating effective treatments for serious health conditions, contributing to advancements in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues, including Hans Kristian Wallberg and Ming-Hua Xu, who have contributed to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of medicinal chemistry.

Conclusion

Xin-Sheng Lei's contributions to the development of metalloproteinase inhibitors highlight his role as an influential inventor in the pharmaceutical industry. His patents reflect a commitment to addressing significant health challenges, particularly in respiratory diseases.